Sure, keep saying that Melky Cabrera cashed in on his PED use

58 Comments

My friend Josh Fisher alerted me to something in Buster Olney’s column over the weekend about the fallout from Melky Cabrera’s positive PED test last year:

Before Melky Cabrera was suspended this past summer, the Giants were engaged in conversations with Cabrera about a deal that would’ve paid the outfielder something in the range of $75 million of $85 million …

He added in an update yesterday that the Giants said a deal wasn’t necessarily close, but there was no denial of the discussions either.

I offer this only as a reminder to those people who like to point to Cabrera’s $16 million deal as some sort of affront and/or proof that taking PEDs pays. To the contrary, Melky’s positive PED test cost him as much as $69 million dollars. SIXTY-NINE MILLION DOLLARS. Plus the salary he lost during his suspension.

I presume we are going to have stiffer PED penalties in the near future. And that the rash of positive tests for testosterone and the like last season are significant reasons for that. But to suggest that there are not deterrents against drug use in place already is ridiculous. It’s just that some people — most notably Melky Cabrera — are too clueless to be deterred.

Report: Nationals sign Matt Adams

Matt Adams
Getty Images
Leave a comment

Free agent first baseman Matt Adams has signed a one-year, $4 million pact with the Nationals, the Athletic’s Ken Rosenthal reports. Official confirmation is still pending completion of a physical.

The 30-year-old infielder will return to familiar turf in Washington after spending the first half of the 2018 season there. He was dealt to the Cardinals in late August for cash considerations and finished the season batting a collective .239/.309/.477 with a career-high 21 home runs, .786 OPS and 0.8 fWAR through 337 plate appearances for the two National League clubs.

Despite his impressive display of power, Adams experienced a significant decline at the plate over the second half of the season, batting well under the Mendoza Line as the Cardinals pushed for a postseason berth against the division-winning Brewers and Wild Card-contending Cubs. Still, he saw enough early success in Washington to merit a second look and should provide a sturdy backup to Ryan Zimmerman at first base in 2019.